EASSA Study Group, c/o CEESA, 168, Av de Tervueren, Brussels, Belgium.
Bayer Animal Health GmbH, Monheim, Germany.
J Antimicrob Chemother. 2019 Apr 1;74(4):921-930. doi: 10.1093/jac/dky537.
The European Antimicrobial Susceptibility Surveillance in Animals (EASSA) programme collects zoonotic and commensal bacteria from healthy food-producing animals at slaughter and tracks their susceptibility to medically important antibiotics. Results for enterococci, collected over three time periods, are presented.
Intestinal contents from cattle, pigs and chickens were randomly sampled (five or six countries/host; at least four abattoirs/country; one sample/animal/farm) for isolation of enterococci; antimicrobial susceptibilities were centrally assessed by CLSI agar dilution. Clinical breakpoints (CLSI) and epidemiological cut-off values (EUCAST) were applied for data interpretation.
In total, 2435 Enterococcus faecium and 1389 Enterococcus faecalis strains were recovered. Seven E. faecium/faecalis strains were linezolid resistant. One E. faecium strain was non-WT (NWT), with a daptomycin MIC of 8 mg/L. Clinical vancomycin resistance was very low or absent; eight strains had decreased susceptibility (MICs of 8 mg/L). Two strains were clinically resistant to tigecycline. Little resistance to ampicillin or gentamicin was observed. Clinical resistance of E. faecium to quinupristin/dalfopristin was slightly higher (2.2%-33.6%) and 38.5%-83.2% of the strains were classified NWT. Very high resistance to tetracycline (67.4%-79.1%) and erythromycin (27.1%-57.0%) was noted for E. faecium and E. faecalis in pigs and chickens. For both of these compounds, similar NWT results were observed for Enterococcus hirae (n = 935), Enterococcus durans (n = 286) and Enterococcus casseliflavus (n = 154) whereas the percentage of NWT for linezolid, tigecycline and vancomycin was generally zero or low.
In this pan-EU survey of commensal enterococci, antibiotic susceptibility varied widely between antibiotics, animal species, countries and enterococcal species. Clinical resistance to antibiotics that are critically important for human medicine was absent or low, except for erythromycin.
欧洲动物抗菌敏感性监测(EASSA)计划从健康的食用动物屠宰时采集人畜共患病和共生细菌,并跟踪其对重要医学抗生素的敏感性。现呈现肠球菌的三个时间段的结果。
从牛、猪和鸡的肠道内容物中随机抽样(每个国家/宿主 5 或 6 个;每个国家至少 4 个屠宰场;每个动物/农场 1 个样本)分离肠球菌;通过 CLSI 琼脂稀释法对抗菌药物敏感性进行集中评估。应用临床折点(CLSI)和流行病学切割值(EUCAST)进行数据分析。
共回收 2435 株屎肠球菌和 1389 株粪肠球菌。7 株屎肠球菌/粪肠球菌对利奈唑胺耐药。1 株屎肠球菌是非野生型(NWT),其达托霉素 MIC 为 8mg/L。临床万古霉素耐药性很低或不存在;8 株对万古霉素的敏感性降低(MICs 为 8mg/L)。2 株对替加环素临床耐药。对氨苄西林或庆大霉素的耐药性较低。肠球菌对喹奴普汀/达福普汀的临床耐药性略高(2.2%-33.6%),38.5%-83.2%的菌株被归类为 NWT。猪和鸡的屎肠球菌和粪肠球菌对四环素(67.4%-79.1%)和红霉素(27.1%-57.0%)的耐药性非常高。对于这两种化合物,肠球菌海氏亚种(n = 935)、肠球菌 durans(n = 286)和肠球菌鹑鸡亚种(n = 154)的 NWT 结果相似,而利奈唑胺、替加环素和万古霉素的 NWT 百分比通常为零或较低。
在这项欧盟范围内的共生肠球菌调查中,抗生素敏感性在抗生素、动物物种、国家和肠球菌种之间差异很大。除红霉素外,临床对重要的人类医学抗生素的耐药性较低或不存在。